# Antagonization of Heparin With Protamine Sulfate After TAVI

> **NCT06215378** · PHASE3 · RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 940 (estimated)

## Conditions studied

- Aortic Valve Stenosis
- Heart Valve Diseases

## Interventions

- **DRUG:** Antagonization of heparin with protamine sulfate

## Key facts

- **NCT ID:** NCT06215378
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-25
- **Primary completion:** 2027-03-01
- **Final completion:** 2027-03-01
- **Target enrollment:** 940 (ESTIMATED)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06215378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06215378, "Antagonization of Heparin With Protamine Sulfate After TAVI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06215378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*